More than 120 medical societies have joined the AMA in a letter urging congressional leaders to enact long-term solutions to the systemic problems in the Medicare physician payment system and to address cuts that are going into effect in 2023.

Yet another lawsuit is taking aim at the Affordable Care Act, and 61 U.S. medical organizations have joined forces to speak out.

The American College of Radiology (ACR) announced this week its government relations staff has been engaging federal agencies in an effort to improve product availability and hasten resolution of the ongoing iodine contrast shortage.

Alan Matsumoto, MD, chair of the department of radiology at the University of Virginia and vice chair of the ACR Board of Chancellors, explains how the ACR and group purchasing organizations are asking the FDA to mitigate the contrast shortage with an emergency use authorization to allow non-FDA cleared iodine contrast agents to be imported.

Gadolinium might be an alternative, stop-gap solution for interventional procedures during the current iodine contrast shortage.

Alan H. Matsumoto, MD, chair of the department of radiology at the University of Virginia and vice chair of the American College of Radiology Board of Chancellors, explains the contrast shortage situation and the tough decisions providers are being forced to make.

Alan H. Matsumoto, MD, chair of the department of radiology at the University of Virginia, vice chair of the American College of Radiology (ACR) Board of Chancellors, and chairman of the ACR Commission on Interventional and Cardiovascular Radiology, explains that the iodine contrast shortage has led to use of MRI gadolinium contrast agents in some cases.